Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdT-cell [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
ADAMTS18	ADAMTS21	ENSG00000140873	"ADAM metallopeptidase with thrombospondin type 1 motif 18"	Q8TE60	16	77247813-77435114	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease mutation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in some"	8	"adipose tissue: 16.1;brain: 31.9;placenta: 27.6"	"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 12.1;TIME: 3.7;U-87 MG: 7.4"	"Low cancer specificity"	"Detected in single"			"Region enriched"	"Detected in all"	5	"cerebellum: 31.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"cerebellum: 3.7"	"Not detected"	"Not detected"			HPA044326	Uncertain		Approved	"Midbody,Mitotic spindle"	"Secreted to extracellular matrix"			"Midbody, Mitotic spindle"		"HPA044326: AB_10961006"	"unprognostic (1.10e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.98e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.20e-2)"	"unprognostic (8.17e-4)"	"unprognostic (1.77e-5)"	"unprognostic (2.17e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.47e-4)"	16.1	0.6	1.1	0.8	5.1	0.4	3.2	31.9	3.3	2.2	0.4	8.2	0.0	0.5	1.6	0.4	0.5	0.7	1.1	0.4	2.0	1.3	0.5	0.3	0.5	0.5	1.8	1.4	0.5	0.8	0.4	1.4	27.6	6.4	1.0	0.4	0.2	2.1	0.5	1.0	0.4	0.4	1.2	3.7	0.3	0.3	0.7	2.4	0.0	0.4	0.0	0.3	0.8	0.4	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	3.7	0.1	0.0	0.0	0.0	0.0	0.0	0.3	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.1	5.1	31.9	3.3	2.0	1.3	1.8	1.4	6.4	2.4
ADAMTS19		ENSG00000145808	"ADAM metallopeptidase with thrombospondin type 1 motif 19"	Q8TE59	5	129460265-129738683	"Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix, uterine: 16.6;endometrium 1: 14.6;smooth muscle: 9.0"	"Group enriched"	"Detected in some"	8	"MCF7: 11.7;SH-SY5Y: 27.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	5	"olfactory region: 4.8"	"Low region specificity"	"Detected in all"			"HPA056171, HPA058438"	Uncertain		Approved	Vesicles,Midbody	"Secreted to extracellular matrix"			"Vesicles, Midbody"		"HPA056171: , HPA058438: "	"unprognostic (1.14e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.49e-2)"		"unprognostic (3.93e-2)"		"unprognostic (4.17e-2)"	"unprognostic (5.99e-3)"	"unprognostic (5.17e-1)"		"unprognostic (1.14e-1)"	"unprognostic (5.88e-2)"		"unprognostic (3.06e-2)"	0.2	1.2	0.7	0.6	3.6	0.1	0.2	0.0	4.9	16.6	0.5	1.2	0.0	0.4	14.6	0.3	1.5	2.6	0.8	0.5	1.0	0.8	0.7	0.1	0.2	0.2	0.5	4.3	2.8	0.2	0.2	0.1	5.3	1.8	0.4	0.6	0.9	1.1	0.2	0.8	0.2	0.3	9.0	1.0	0.2	0.2	0.4	0.8	0.0	0.1	1.8	0.1	0.9	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	27.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	3.6	0.0	4.9	1.0	0.8	0.5	4.3	1.8	0.8
ANLN	"ANILLIN, scra, Scraps"	ENSG00000011426	"Anillin actin binding protein"	Q9NQW6	7	36389806-36453791	"Disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Actin-binding	"Disease mutation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 63.4;lymphoid tissue: 32.7"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 98.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enhanced"	"Detected in single"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005680, CAB033902, HPA050556, CAB062547, CAB068175"	Enhanced		Enhanced	Nucleoplasm,Midbody				Nucleoplasm	Midbody	"CAB033902: AB_2058302, CAB062547: , CAB068175: , HPA005680: , HPA050556: "	"unprognostic (4.23e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.49e-1)"	"prognostic unfavourable (1.73e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.44e-2)"	"prognostic unfavourable (5.97e-7)"	"prognostic unfavourable (6.99e-5)"	"unprognostic (2.69e-2)"	"unprognostic (3.66e-2)"	"prognostic unfavourable (2.00e-6)"	"unprognostic (3.13e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (5.29e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.94e-2)"	"unprognostic (4.04e-3)"	1.7	0.6	13.9	7.2	10.5	20.9	1.3	1.8	36.7	1.9	3.9	1.6	0.0	2.9	1.3	2.4	12.8	0.6	1.4	0.6	24.0	12.1	0.7	0.8	3.3	4.2	30.5	2.5	0.9	0.4	0.3	0.3	12.9	9.7	0.7	5.5	0.0	0.9	0.3	0.4	8.9	3.4	9.4	63.4	1.6	3.3	9.2	12.5	32.7	0.6	17.7	6.7	2.6	1.3	0.0	0.3	0.6	0.9	0.0	1.7	2.0	67.1	14.1	11.7	8.9	1.6	4.1	12.7	42.4	24.8	51.2	38.4	9.6	20.8	3.4	12.3	21.4	34.6	9.2	24.8	98.4	2.2	6.7	4.6	15.9	8.0	0.2	6.6	5.4	0.9	1.1	33.3	22.0	15.9	9.7	7.1	41.7	10.1	5.6	7.7	13.0	15.0	4.1	35.3	2.2	11.3	11.0	5.0	5.9	22.3	25.9	3.9	17.5	7.6	15.1	32.1	36.1	18.9	49.5	3.0	4.7	6.2	10.9	10.7	67.3	0.0	0.9	0.1	0.0	0.2	0.0	0.0	0.9	0.5	0.3	0.0	0.6	0.0	0.6	0.0	0.3	0.2	1.7	2.0	13.9	10.5	1.8	7.7	24.0	12.1	30.5	2.5	9.7	12.5
AURKB	"Aik2, AIM-1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5"	ENSG00000178999	"Aurora kinase B"	Q96GD4	17	8204733-8210600	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 19.7;lymphoid tissue: 59.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in many"		"T-reg: 10.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 10.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB005862, HPA037708"	Enhanced		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"CAB005862: AB_449204, HPA037708: "	"unprognostic (4.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (6.05e-2)"	"prognostic unfavourable (1.24e-4)"	"unprognostic (1.99e-3)"	"unprognostic (9.41e-3)"	"unprognostic (3.47e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.01e-2)"	"prognostic unfavourable (0.00e+0)"	"unprognostic (7.77e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.77e-1)"	1.2	1.3	0.4	22.1	0.6	19.7	2.0	0.6	0.6	2.6	5.8	0.5	0.9	5.9	0.9	1.3	17.1	0.3	2.2	1.0	0.4	0.2	1.4	1.8	2.4	17.8	0.4	0.4	0.8	0.6	0.0	0.4	3.8	0.8	0.9	5.5	0.7	2.7	0.4	2.1	5.0	8.1	1.3	0.7	11.2	4.2	1.2	0.4	59.9	0.5	8.0	19.1	2.1	5.0	2.3	0.8	1.2	0.6	0.5	10.9	1.4	41.0	28.2	42.0	20.2	0.9	1.4	16.1	19.7	10.6	40.8	37.7	36.5	12.4	41.0	10.2	7.8	30.2	30.5	13.5	33.8	18.0	50.1	24.4	16.1	30.8	0.1	12.9	24.0	0.7	0.6	23.9	15.0	18.8	15.2	15.9	17.9	19.5	46.8	18.3	26.1	12.6	31.7	38.7	17.0	8.9	8.1	9.1	13.0	17.5	7.9	13.4	13.8	8.7	7.3	16.4	16.9	14.7	51.2	11.6	7.7	30.8	7.9	19.6	33.1	0.0	0.6	0.9	0.6	0.4	0.2	1.6	1.9	3.1	0.8	2.3	0.2	1.0	1.2	0.5	0.3	0.2	10.9	1.4	0.4	0.6	0.6	0.6	0.4	0.2	0.4	0.4	0.8	0.4
CHMP1B	"C18orf2, CHMP1.5, Vps46B"	ENSG00000255112	"Charged multivesicular body protein 1B"	Q7LBR1	18	11851396-11854449	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"skeletal muscle: 250.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA061997, HPA062896"	Supported		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"HPA061997: , HPA062896: "	"unprognostic (6.73e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.09e-2)"	"unprognostic (6.74e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.35e-3)"	"unprognostic (1.44e-1)"	"unprognostic (8.44e-3)"	"unprognostic (1.90e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.37e-3)"	"unprognostic (9.20e-2)"	"prognostic favourable (7.37e-8)"	"unprognostic (1.88e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.92e-1)"	16.0	13.6	14.9	12.5	11.6	19.5	13.3	8.8	16.0	10.1	14.1	10.0	13.8	14.0	10.4	14.7	14.5	9.1	14.6	17.0	11.2	12.3	12.2	11.2	11.3	14.0	11.6	11.9	11.3	11.2	9.7	12.4	11.8	12.1	10.3	14.1	9.4	12.6	29.5	250.9	15.2	20.4	11.6	13.8	11.3	12.8	6.8	10.0	14.2	19.9	19.4	9.9	14.3	10.1	6.7	13.1	34.4	16.5	7.4	9.1	10.6	12.8	12.6	16.4	13.8	21.5	15.1	23.8	13.8	23.3	9.4	12.6	16.3	13.0	8.0	20.7	14.9	11.0	7.4	19.2	8.4	7.4	9.2	5.8	19.2	13.4	15.9	22.1	10.0	21.9	41.6	10.5	24.5	13.6	9.8	10.4	14.8	15.9	15.3	17.0	6.8	6.3	7.9	8.4	13.7	25.2	17.7	16.0	16.0	23.4	11.0	21.1	9.0	20.4	19.8	21.2	11.2	16.7	14.7	12.5	14.3	10.2	19.6	10.3	10.0	10.9	16.5	27.7	7.2	15.3	6.6	6.5	6.7	8.5	13.1	6.7	8.4	7.7	34.4	7.4	15.0	11.7	9.1	10.6	14.9	11.6	8.8	16.0	11.2	12.3	11.6	11.9	12.1	10.0
DEFA5	"DEF5, HD-5"	ENSG00000164816	"Defensin alpha 5"	Q01523	8	7055304-7056734	"Plasma proteins, Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	231	"intestine: 574.2"	"Group enriched"	"Detected in some"	8	"BEWO: 19.5;NB-4: 16.0;RPMI-8226: 16.8;SH-SY5Y: 13.7;U-2197: 5.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 181.1;colorectal cancer: 147.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA015309, HPA015775, CAB069919"	Enhanced		Approved	Vesicles,Midbody	"Secreted to digestive system"			Vesicles	Midbody	"CAB069919: AB_905358, HPA015309: , HPA015775: AB_1847594"			"prognostic favourable (9.44e-5)"											"unprognostic (3.91e-2)"				0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.1	0.1	0.1	408.9	0.0	0.0	249.9	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	574.2	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	1.7	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	2.4	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0
DTNBP1	"BLOC1S8, DBND, Dysbindin, HPS7, My031"	ENSG00000047579	"Dystrobrevin binding protein 1"	Q96EV8	6	15522801-15663058	"Disease related genes, Predicted intracellular proteins"	"Sensory transduction"		"Albinism, Hermansky-Pudlak syndrome, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 91.0"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028053, HPA029615, HPA029616"	Approved		Enhanced	Microtubules,Midbody				Microtubules	Midbody	"HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413"	"unprognostic (2.83e-1)"	"prognostic favourable (2.82e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavourable (8.72e-4)"	"prognostic favourable (6.34e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.28e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.09e-2)"	7.2	5.0	22.8	10.5	91.0	9.3	7.7	6.7	18.4	6.8	10.5	7.8	4.5	7.2	8.0	12.5	7.2	6.9	7.9	12.0	15.0	18.0	11.3	5.0	8.4	16.9	18.5	10.3	7.3	6.7	13.1	8.5	9.3	13.7	8.1	10.9	13.4	6.7	10.1	15.4	7.1	7.6	11.9	9.4	10.2	7.6	5.5	17.2	9.3	7.8	2.7	19.4	8.6	8.1	17.8	17.9	8.1	7.1	26.9	12.1	6.6	15.5	6.8	5.8	12.5	8.5	9.7	8.9	8.0	10.5	19.4	17.5	8.9	7.2	22.0	21.7	11.3	5.4	11.4	8.5	17.6	14.1	15.2	15.4	8.9	13.2	14.9	15.5	13.2	9.2	13.1	9.8	14.6	17.0	14.6	5.5	11.6	18.3	16.2	24.8	4.1	9.8	19.2	11.4	17.2	18.0	16.3	11.9	5.0	6.3	15.1	18.9	10.9	10.0	7.8	10.9	7.2	11.3	14.7	14.9	28.3	15.5	5.1	13.8	20.7	5.9	5.9	8.1	12.1	7.1	8.0	13.7	10.3	10.4	6.4	17.8	9.8	7.9	6.8	26.9	4.9	17.9	6.9	6.6	22.8	91.0	6.7	18.4	15.0	18.0	18.5	10.3	13.7	17.2
KIF4A	"FLJ12530, FLJ12655, FLJ14204, FLJ20631, HSA271784, KIF4, KIF4-G1, MRX100"	ENSG00000090889	"Kinesin family member 4A"	O95239	X	70290090-70420832	"Predicted intracellular proteins"		"DNA-binding, Motor protein"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.1;lymphoid tissue: 19.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"T-reg: 3.2"	"Lineage enriched"	"Detected in single"	5	"T-cells: 3.2"									"HPA034745, HPA034746, HPA061583"	Approved		Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: "	"unprognostic (8.17e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.46e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavourable (7.37e-6)"	"unprognostic (2.18e-3)"	"unprognostic (5.06e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavourable (9.44e-6)"	"unprognostic (3.79e-2)"	"unprognostic (0.00e+0)"	"unprognostic (3.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	0.9	0.6	0.8	3.3	1.0	11.1	0.5	0.4	3.4	1.2	4.1	0.4	0.4	3.4	0.8	0.4	7.4	1.5	2.5	2.0	0.8	1.3	0.7	0.7	1.5	5.8	0.5	0.9	0.4	0.4	0.0	1.3	2.4	0.8	0.7	5.2	0.4	1.2	0.4	0.8	2.3	3.6	1.2	0.5	4.9	2.1	7.5	1.1	19.3	0.4	0.4	7.2	1.1	2.0	0.7	0.0	0.0	0.2	0.2	3.2	0.3	22.4	15.7	23.8	11.7	1.1	2.0	9.4	17.1	9.2	23.4	20.4	17.6	13.2	13.8	10.8	8.4	13.5	25.7	9.3	26.4	15.8	12.9	15.6	19.2	12.5	0.2	17.3	10.9	0.6	0.5	19.4	11.1	14.3	19.8	30.8	22.0	14.4	15.8	8.6	24.0	16.7	17.6	32.1	13.0	5.6	8.9	15.7	13.1	27.9	11.8	7.3	9.5	6.8	9.9	15.5	20.2	16.6	20.3	8.9	15.2	20.0	8.2	19.1	23.3	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.4	1.3	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	3.2	0.3	0.8	1.0	0.4	3.4	0.8	1.3	0.5	0.9	0.8	1.1
KIF4B		ENSG00000226650	"Kinesin family member 4B"	Q2VIQ3	5	155013755-155018132	"Plasma proteins, Predicted intracellular proteins"		"DNA-binding, Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	33	"testis: 9.0"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.4"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA034745, HPA034746, HPA061583"	Uncertain		Uncertain	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"HPA034745: AB_10670978, HPA034746: AB_10670173, HPA061583: "	"unprognostic (9.87e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.71e-1)"		"unprognostic (4.76e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.37e-2)"		"unprognostic (6.48e-9)"	"unprognostic (7.24e-2)"	"unprognostic (5.10e-2)"		"unprognostic (1.71e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0			0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	0.4	0.1	0.0	0.1	0.6	0.0	0.1	0.2	0.0	0.9	0.0	0.5	0.0	0.5	0.1	0.0	0.1	0.7	0.0	0.4	1.0	0.4	0.0	0.4	0.7	0.0	0.3	0.2	0.0	1.1	0.2	2.4	0.4	0.0	0.8	0.5	0.5	0.5	0.7	1.1	1.0	0.0	0.7	0.5	0.5	1.3	0.2	0.3	0.5	0.5	0.2	0.7	1.2	0.7	1.2	0.4	0.6	0.5	0.4	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0										
LBX2		ENSG00000179528	"Ladybird homeobox 2"	Q6XYB7	2	74497517-74503316	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"liver: 13.8"	"Cell line enhanced"	"Detected in many"		"CACO-2: 9.1;Hep G2: 18.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebellum: 1.3;olfactory region: 0.9"	HPA044257	Uncertain		Approved	Nucleoplasm,Midbody				Nucleoplasm	Midbody	"HPA044257: "	"unprognostic (5.24e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.35e-5)"	"unprognostic (8.22e-4)"	"unprognostic (2.95e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.43e-5)"	"unprognostic (5.77e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.87e-2)"	4.4	0.4	1.5	1.0	0.5	0.3	1.3	0.5	0.5	1.1	6.8	0.0	1.5	8.3	2.2	2.6	0.5	0.6	3.9	1.8	0.3	0.3	1.9	13.8	3.7	0.4	0.3	0.6	0.6	3.4	0.0	0.3	2.6	0.5	0.6	0.0	0.2	1.5	0.4	0.8	1.3	7.3	0.1	0.4	1.9	4.9	1.3	0.0	0.3	1.1	1.7	2.1	0.8	0.6	0.2	2.1	1.6	4.8	2.5	1.0	1.5	3.7	1.3	0.0	0.1	1.7	1.4	6.4	0.3	0.2	0.4	0.4	9.1	5.6	0.2	1.5	0.7	1.5	0.0	0.2	0.0	7.8	1.7	4.0	0.5	18.9	1.3	0.2	2.6	1.8	1.4	1.4	0.3	1.6	2.6	2.0	0.3	1.9	0.1	0.8	0.4	0.2	0.4	0.4	0.2	0.2	1.2	0.2	1.0	2.3	0.3	8.3	0.2	0.3	3.6	1.4	6.0	7.3	0.1	2.5	1.9	0.2	1.4	0.7	4.2	0.8	4.0	0.3	0.8	1.9	0.5	0.2	0.2	1.0	2.1	0.2	0.2	0.7	1.6	2.5	4.8	0.6	0.1	1.5	1.5	0.5	0.5	0.5	0.3	0.3	0.3	0.6	0.5	0.0
LYRM1	A211C6.1	ENSG00000102897	"LYR motif containing 1"	O43325	16	20899868-20925006	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 101.6"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059840			Supported	Nucleoplasm,Midbody				Nucleoplasm	Midbody	"HPA059840: "	"unprognostic (4.44e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-2)"	"prognostic favourable (7.48e-7)"	"unprognostic (3.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.39e-1)"	"prognostic unfavourable (4.80e-4)"	"unprognostic (1.57e-1)"	"unprognostic (6.18e-2)"	"unprognostic (3.86e-1)"	"prognostic favourable (9.50e-4)"	25.4	18.9	19.1	15.0	17.4	12.8	25.5	12.6	17.8	17.5	16.6	9.6	14.0	9.5	17.1	21.1	16.2	24.9	17.0	34.2	15.4	18.2	30.6	101.6	11.2	19.2	18.8	13.8	25.3	26.1	20.5	13.9	9.0	24.9	21.1	14.0	13.1	14.1	19.1	28.7	10.6	12.6	27.6	17.9	11.5	15.7	22.9	9.0	16.2	19.4	14.9	12.9	25.3	19.7	12.7	7.2	47.4	10.2	8.4	14.2	10.1	11.8	12.8	11.9	9.4	32.3	25.7	3.9	9.9	16.6	5.7	8.7	14.3	14.9	8.4	38.7	11.9	8.4	5.2	10.4	9.4	15.6	8.1	3.8	3.5	36.9	24.0	12.4	7.5	18.6	9.2	16.0	46.0	23.6	8.4	14.8	24.7	15.8	12.3	8.4	12.4	6.7	16.9	6.6	10.0	20.6	7.0	11.6	11.2	6.1	10.3	16.5	10.6	7.3	6.2	8.2	6.0	12.9	6.8	14.7	20.5	13.1	21.5	13.4	7.1	47.4	7.2	23.3	8.6	9.1	11.8	12.7	13.2	10.6	5.9	11.2	10.7	10.8	26.8	8.4	10.2	7.2	14.2	10.1	19.1	17.4	12.6	17.8	15.4	18.2	18.8	13.8	24.9	9.0
MBD5	"FLJ11113, KIAA1461"	ENSG00000204406	"Methyl-CpG binding domain protein 5"	Q9P267	2	148021011-148516971	"Disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035964			Supported	Nucleoplasm,Midbody				"Nucleoplasm, Midbody"		"HPA035964: "	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavourable (3.72e-4)"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.86e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.12e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.82e-1)"	8.5	11.3	13.9	14.1	13.7	6.8	9.0	26.1	14.7	13.7	16.3	10.1	8.9	7.2	12.6	8.7	9.9	9.6	13.4	10.3	11.7	10.6	13.7	6.9	8.2	8.7	9.3	9.9	14.2	5.7	25.5	24.7	10.4	11.3	11.5	8.1	10.8	7.5	11.6	9.9	6.6	8.2	15.7	11.8	9.8	9.1	11.0	12.5	17.3	12.8	6.0	8.6	15.1	10.1	1.3	1.1	3.6	1.2	1.0	2.2	0.7	1.4	1.5	9.0	6.5	6.5	7.4	4.0	6.7	7.3	4.5	3.8	3.4	4.5	2.5	1.7	5.7	1.0	4.7	7.4	6.4	2.2	2.2	5.4	4.9	1.7	2.7	0.7	0.8	5.6	6.5	6.0	4.0	7.5	2.0	6.1	7.6	3.4	2.9	3.9	3.0	2.4	2.9	1.5	0.9	6.0	7.2	5.2	7.3	4.3	2.3	4.5	2.9	4.5	5.5	5.3	2.2	0.7	2.8	4.4	1.7	2.2	9.0	2.5	6.1	3.6	0.4	1.9	1.6	0.3	1.1	0.7	1.8	1.5	0.9	1.3	1.4	2.2	0.6	1.0	1.2	1.1	0.6	0.7	13.9	13.7	26.1	14.7	11.7	10.6	9.3	9.9	11.3	12.5
MED9	"FLJ10193, MED25"	ENSG00000141026	"Mediator complex subunit 9"	Q9NWA0	17	17476986-17493226	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056415	Uncertain		Approved	Nucleoplasm,Midbody				Nucleoplasm	Midbody	"HPA056415: "	"unprognostic (1.81e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.21e-2)"	"unprognostic (4.23e-1)"	"unprognostic (7.65e-2)"	"prognostic favourable (4.18e-5)"	"unprognostic (3.96e-2)"	"prognostic favourable (2.83e-9)"	"unprognostic (2.26e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.39e-1)"	10.2	12.7	16.0	6.5	23.5	12.3	14.1	16.3	29.1	13.0	11.2	9.2	10.9	11.2	11.7	17.3	8.2	11.7	6.6	30.0	14.3	13.6	13.9	19.1	8.2	11.5	13.6	14.5	12.4	10.2	20.3	11.3	7.9	12.6	11.4	10.5	8.9	15.8	14.9	34.4	11.3	10.5	8.6	10.3	9.5	10.1	12.9	8.6	14.9	13.4	15.2	9.1	7.5	7.8	11.4	12.8	11.8	11.4	10.3	13.4	7.4	8.5	11.0	9.5	10.2	7.6	6.9	8.1	7.0	8.7	10.8	9.8	15.9	4.3	10.6	8.1	7.2	11.2	12.0	9.7	10.3	6.7	19.1	6.4	7.3	11.4	8.2	5.1	5.6	11.2	9.2	9.1	9.4	7.4	7.6	4.9	7.2	7.2	22.9	10.6	8.7	11.3	17.8	21.4	6.8	9.5	6.1	6.2	9.8	9.2	7.3	15.5	8.6	6.7	5.0	8.0	9.3	13.7	11.0	9.3	6.6	5.9	10.1	9.1	8.4	2.7	7.0	11.8	10.3	9.6	13.4	11.4	10.7	10.6	7.8	10.4	11.6	12.8	2.4	10.3	11.4	12.8	10.3	7.4	16.0	23.5	16.3	29.1	14.3	13.6	13.6	14.5	12.6	8.6
MSL2	"FLJ10546, KIAA1585, msl-2, MSL2L1, RNF184"	ENSG00000174579	"MSL complex subunit 2"	Q9HCI7	3	136148922-136197241	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003339, HPA003413"	Uncertain		Approved	Nucleoplasm,Midbody				Nucleoplasm	Midbody	"HPA003339: , HPA003413: AB_1848659"	"unprognostic (9.86e-2)"	"prognostic favourable (4.80e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.41e-2)"	"unprognostic (8.11e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.62e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.54e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.79e-3)"	"unprognostic (4.54e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.76e-3)"	13.1	10.1	13.3	16.2	15.6	40.2	13.5	31.0	15.8	13.7	11.3	14.8	9.9	11.1	15.5	8.2	12.2	14.1	10.0	9.8	12.4	9.0	10.0	14.1	13.4	23.7	12.6	11.2	18.3	12.7	19.9	19.8	15.9	12.0	13.0	10.1	10.6	13.2	9.8	14.9	14.1	18.2	9.6	14.2	24.2	12.3	13.6	15.6	59.3	13.8	7.4	23.9	13.4	12.9	7.6	3.8	8.7	3.9	6.6	13.3	5.4	12.5	4.2	8.6	9.8	6.0	6.7	15.7	7.6	6.4	6.1	6.1	8.3	6.6	23.5	10.5	5.6	9.0	9.9	6.6	9.6	12.4	7.6	25.6	8.3	4.7	6.2	21.0	13.4	5.2	7.2	5.0	14.1	6.1	9.1	20.4	5.1	7.7	37.9	12.3	11.5	7.3	17.7	14.7	14.9	3.0	8.9	11.2	8.0	17.3	7.1	11.5	6.3	13.8	9.5	8.3	7.2	7.6	7.0	24.2	12.6	35.1	7.0	9.0	5.5	5.2	3.7	5.0	7.0	3.9	8.8	4.5	6.6	8.2	3.8	7.6	13.3	8.9	8.7	6.6	2.8	2.5	5.0	5.4	13.3	15.6	31.0	15.8	12.4	9.0	12.6	11.2	12.0	15.6
NAT10	"FLJ10774, FLJ12179, hALP, KIAA1709, Kre33, NET43"	ENSG00000135372	"N-acetyltransferase 10"	Q9H0A0	11	34105602-34147670	"Plasma proteins, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB035546, HPA057576, HPA071628"	Approved		Enhanced	Nucleoli,Midbody				Nucleoli	Midbody	"CAB035546: , HPA057576: , HPA071628: "	"unprognostic (3.04e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavourable (1.07e-4)"	"prognostic unfavourable (9.61e-8)"	"unprognostic (1.15e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavourable (8.83e-5)"	"unprognostic (1.24e-1)"	"unprognostic (7.18e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.69e-2)"	18.5	22.8	20.5	21.9	27.5	23.6	20.8	21.9	29.9	18.1	17.6	24.3	16.4	13.7	30.6	19.8	25.2	21.7	14.7	16.4	17.2	18.6	15.9	21.8	15.1	28.7	16.9	19.8	26.4	24.9	31.5	23.1	20.1	23.4	19.5	21.7	23.0	22.5	17.8	23.4	31.0	16.6	21.5	15.1	23.6	18.0	30.9	16.9	31.2	18.3	19.4	35.3	17.8	19.7	10.4	12.8	2.2	11.1	11.8	13.7	6.9	12.2	17.3	9.3	19.7	11.2	10.0	10.8	12.2	9.0	15.5	12.4	19.4	7.1	39.4	9.1	10.3	18.7	34.9	18.6	19.9	10.9	22.4	17.9	14.2	18.1	10.2	44.7	13.0	10.1	12.8	10.1	28.6	11.8	38.9	13.8	12.9	23.3	36.4	20.3	13.3	20.9	27.4	31.5	16.4	8.9	21.5	13.8	10.5	16.4	17.5	7.3	17.5	12.3	9.5	13.9	11.0	20.3	22.6	15.1	18.1	37.6	14.0	18.6	13.7	0.5	6.6	2.2	10.3	11.1	13.7	10.4	11.1	11.7	12.8	9.6	11.5	11.2	0.8	11.8	9.7	9.7	9.6	6.9	20.5	27.5	21.9	29.9	17.2	18.6	16.9	19.8	23.4	16.9
ST8SIA5	SIAT8E	ENSG00000101638	"ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5"	O15466	18	46667821-46759257	"Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 12.8;brain: 36.4"	"Cell line enriched"	"Detected in some"	8	"WM-115: 51.7"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.6"	"Region enhanced"	"Detected in many"		"cerebellum: 36.4"	"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043813, HPA046771"	Approved		Approved	"Plasma membrane,Midbody"				"Plasma membrane, Midbody"		"HPA043813: , HPA046771: "	"unprognostic (3.19e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.33e-4)"	"unprognostic (2.99e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.55e-2)"	"unprognostic (8.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.79e-2)"	0.6	12.8	3.6	0.6	7.8	0.9	0.5	36.4	16.1	0.5	0.5	1.0	0.0	0.7	0.5	0.9	0.4	0.7	0.6	7.2	4.0	1.8	1.5	0.4	0.5	0.5	2.0	6.9	0.7	0.4	4.9	0.7	0.4	4.1	0.6	0.5	0.0	0.4	0.5	8.2	0.7	0.5	0.5	2.5	0.5	0.7	0.9	0.7	0.0	0.6	0.0	0.5	0.5	0.1	0.8	0.4	1.5	0.4	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.5	3.0	0.1	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	51.7	1.0	0.4	0.2	0.2	0.2	0.2	0.4	0.2	0.2	0.0	0.8	0.3	0.3	1.5	0.5	0.2	0.4	0.1	0.0	3.6	7.8	36.4	16.1	4.0	1.8	2.0	6.9	4.1	0.7
TMEM125	MGC17299	ENSG00000179178	"Transmembrane protein 125"	Q96AQ2	1	43269994-43274002	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in many"		"pancreas: 73.6;salivary gland: 47.8"	"Cell line enhanced"	"Detected in some"		"A-431: 13.5;BEWO: 11.6;CACO-2: 10.6;CAPAN-2: 25.2;SK-BR-3: 21.7;T-47d: 17.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"NK-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA015796			Approved	Midbody,Cytosol				"Midbody, Cytosol"		"HPA015796: AB_1858081"	"unprognostic (2.53e-3)"	"unprognostic (8.70e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.50e-2)"	"unprognostic (8.37e-3)"	"prognostic favourable (5.11e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-1)"	"prognostic favourable (2.91e-9)"	"unprognostic (1.86e-2)"	"unprognostic (2.19e-1)"	"unprognostic (4.04e-1)"	"unprognostic (5.16e-2)"	0.8	0.0	5.3	4.6	7.1	0.0	4.9	0.9	5.0	7.4	14.4	1.0	20.7	15.1	1.8	12.5	3.3	6.6	18.9	1.0	8.9	4.3	9.4	1.4	42.5	0.8	10.7	0.8	2.0	73.6	9.6	15.7	5.6	1.1	8.8	9.1	1.5	47.8	19.0	0.8	3.7	29.4	0.8	21.1	0.8	11.6	1.2	0.8	1.1	33.6	3.8	5.0	1.4	3.5	0.0	0.8	0.0	0.0	1.8	0.9	0.2	13.5	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.0	0.0	0.0	10.6	25.2	0.0	0.6	0.0	6.1	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.2	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.2	4.3	6.6	0.0	0.0	21.7	0.0	17.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.9	0.2	0.0	1.8	0.0	0.8	0.0	0.2	5.3	7.1	0.9	1.9	8.9	4.3	10.7	0.8	1.1	0.8
TMEM86B	MGC30208	ENSG00000180089	"Transmembrane protein 86B"	Q8N661	19	55226639-55229264	"Enzymes, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in all"		"liver: 15.1"	"Low cell line specificity"	"Detected in many"			"Cancer enriched"	"Detected in all"	5	"liver cancer: 10.0"	"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057689	Uncertain		Uncertain	Midbody,Centrosome				Centrosome	Midbody	"HPA057689: "	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.76e-5)"	"unprognostic (1.87e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.55e-2)"	"prognostic favourable (3.13e-4)"	"unprognostic (1.10e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.10e-1)"	"prognostic favourable (9.97e-6)"	"unprognostic (1.96e-2)"	"unprognostic (6.63e-8)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.19e-3)"	2.5	2.4	2.8	3.1	4.0	7.8	1.4	4.7	4.2	1.4	7.5	1.4	1.4	5.6	1.5	1.4	1.4	1.8	7.7	2.9	2.2	1.6	2.0	15.1	2.7	5.2	1.4	1.4	1.4	1.4	1.7	2.8	5.2	1.7	1.5	0.4	1.4	1.4	1.4	2.2	3.0	7.7	1.4	1.4	4.3	3.6	2.8	1.4	1.4	2.3	1.4	3.0	1.4	1.4	0.7	1.0	0.6	0.7	0.0	1.6	0.4	4.1	3.9	2.4	3.9	0.4	0.6	3.6	1.4	0.7	1.3	1.8	6.3	2.2	4.7	1.2	1.1	1.7	0.9	1.0	0.6	0.9	11.1	8.8	2.5	5.9	1.2	3.9	3.7	0.8	1.7	2.1	1.3	0.5	6.0	3.5	0.8	2.4	6.4	10.0	0.9	2.4	5.9	2.8	12.5	1.1	5.1	2.1	3.9	1.8	0.8	4.9	2.2	8.3	2.8	5.7	3.2	2.5	3.8	2.9	3.4	10.2	4.7	11.1	2.1	0.0	0.7	0.6	1.6	0.1	0.6	0.0	0.5	0.1	0.1	0.7	0.6	1.4	0.1	0.0	0.1	1.0	0.0	0.4	2.8	4.0	4.7	4.2	2.2	1.6	1.4	1.4	1.7	1.4
WIZ	ZNF803	ENSG00000011451	"Widely interspaced zinc finger motifs"	O95785	19	15419980-15449951	"Plasma proteins, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"HPA022923, HPA023774"	Supported		Enhanced	Nucleoplasm,Midbody				Nucleoplasm	Midbody	"HPA022923: AB_1858845, HPA023774: "	"unprognostic (3.50e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.21e-2)"	"prognostic unfavourable (5.12e-5)"	"unprognostic (1.05e-1)"	"unprognostic (4.96e-3)"	"unprognostic (9.73e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.24e-2)"	"unprognostic (4.69e-2)"	"unprognostic (7.46e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.65e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.11e-1)"	28.0	17.5	27.6	18.3	21.6	13.6	20.9	15.8	24.4	17.5	17.3	12.8	18.0	18.2	25.2	12.0	16.3	16.3	15.3	17.3	23.0	11.4	13.8	18.4	13.5	17.5	14.1	19.0	21.6	26.9	14.3	10.9	13.7	13.7	17.4	7.7	12.4	21.9	23.1	24.4	21.5	16.8	16.5	11.9	18.0	15.6	40.9	15.8	18.6	13.3	14.6	12.1	19.3	21.4	2.0	1.5	0.7	3.6	2.5	1.2	0.5	13.5	9.2	13.3	16.9	19.2	7.9	10.8	14.2	6.9	11.8	8.2	8.1	25.3	11.2	23.3	12.8	11.5	7.3	9.9	2.9	8.7	12.5	8.2	7.2	6.4	12.2	9.4	12.2	13.9	13.1	8.5	9.3	10.6	12.7	9.7	8.0	27.4	17.0	8.7	18.0	22.1	15.9	6.1	11.3	7.7	10.5	18.2	23.1	12.4	11.3	9.1	12.4	8.9	17.1	27.1	10.8	21.3	18.0	14.3	8.5	12.1	11.3	11.3	18.2	0.0	1.4	0.0	1.2	1.2	1.0	0.5	0.8	1.2	1.0	2.0	1.0	1.0	0.7	2.5	3.6	1.5	0.8	0.5	27.6	21.6	15.8	24.4	23.0	11.4	14.1	19.0	13.7	15.8
